Stay updated on Seladelpar in PBC with Compensated Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC with Compensated Cirrhosis Clinical Trial page.

Latest updates to the Seladelpar in PBC with Compensated Cirrhosis Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label updates from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now displays a 403 Forbidden error page with a basic HTML skeleton and site chrome (doctype, meta tags, title, header, and footer). This indicates that access to the study record is blocked.SummaryDifference18%

- Check48 days agoChange DetectedThe study page's revision label was updated from v3.6.5 to v3.6.6. This reflects a minor update to the record rather than changes to core content.SummaryDifference0.0%

- Check62 days agoChange DetectedNew recruitment sites were added across several countries (Portugal, Germany, France, Czechia, the United States, Singapore) and the total number of locations was updated from 205 to 211, reflecting updates to the study's geographic reach.SummaryDifference0.5%

- Check69 days agoChange DetectedThe page's revision tag updates from v3.6.4 to v3.6.5. This signals a new build or content update for the study details page.SummaryDifference0.0%

- Check83 days agoChange DetectedFooter now shows Revision: v3.6.4, replacing the previous v3.6.3. This reflects a minor revision to the page metadata and does not alter the study content.SummaryDifference0.0%

Stay in the know with updates to Seladelpar in PBC with Compensated Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC with Compensated Cirrhosis Clinical Trial page.